Latest filing published 28 Feb 2018 for Mimedx Group, INC., €27k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -17.2%Entry US$1.45 · Close at T+365 US$1.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Charles Taylor: trading record in brief
William Charles Taylor is a declared insider of Mimedx Group, Inc., with filings sourced from SEC (Form 4). We count 59 filings; the first trade dates from 28 December 2009 and the latest from 27 February 2018.
In open-market terms, that means 1 purchase worth €17k on one side and 22 sales worth €6.7M on the other. On balance, insiders were net sellers of €6.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 17 share grants and 19 option exercises.
The latest filing, published on 28 February 2018, reports an option exercise of €27k in Mimedx Group, Inc. The last insider purchase was made public on 30 December 2009, 6,157 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Charles Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$1.650.8% of flowCommon StockSEC:0001376339-18-000018:0
- 8,805 shares@ US$8.881.9% of flowCommon StockSEC:0001376339-18-000016:0
- 15,175 shares@ US$8.883.2% of flowCommon StockSEC:0001376339-18-000016:1
- 90,900 shares@ US$8.8819.2% of flowCommon StockSEC:0001376339-18-000016:2
- 7,287 shares@ US$7.831.4% of flowCommon StockSEC:0001376339-18-000016:3
- 10,000 shares0Common StockSEC:0001376339-17-000146:0
- 13,812 shares@ US$7.242.6% of flowCommon StockSEC:0001376339-17-000104:0
- 80,000 shares@ US$14.5230.3% of flowCommon StockSEC:0001376339-17-000104:1
- 26,571 shares@ US$13.749.5% of flowCommon StockSEC:0001376339-17-000102:0
- 19,723 shares@ US$5.072.7% of flowCommon StockSEC:0001376339-17-000078:0
- 26,000 shares@ US$11.408.0% of flowCommon StockSEC:0001376339-17-000071:0
- 26,000 shares@ US$8.185.9% of flowCommon StockSEC:0001376339-17-000044:0
- 11,929 shares0Common StockSEC:0001376339-17-000035:0
- 150,000 shares0Common StockSEC:0001376339-17-000028:0
- 9,981 shares0Common StockSEC:0001376339-17-000028:1
- 20,400 shares@ US$7.554.0% of flowCommon StockSEC:0001376339-16-000205:0
- 3,762 shares@ US$7.530.7% of flowCommon StockSEC:0001376339-16-000200:0
- 350 shares@ US$7.500.1% of flowCommon StockSEC:0001376339-16-000200:1
- 25,000 shares@ US$7.554.9% of flowCommon StockSEC:0001376339-16-000200:2
- 24,333 shares@ US$7.524.8% of flowCommon StockSEC:0001376339-16-000191:0
- 6,114 shares0Common StockSEC:0001376339-16-000148:0
- 4,058 shares0Common StockSEC:0001376339-16-000140:0
- 8,008 shares0Common StockSEC:0001376339-16-000140:1
- 85,000 shares0Common StockSEC:0001376339-16-000129:0
- 40,606 shares@ US$1.65Common StockSEC:0001376339-15-000095:0
25 of 59 declarations